Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oops, He Did It Again – Another Charge Against Shkreli

Executive Summary

Prosecutors unsealed an additional charge of conspiracy to commit securities fraud against Martin Shkreli – infamously known for hiking up the price of a toxoplasmosis medicine by 5,000% – bringing the total number of criminal counts against the former drug company CEO to eight.

Advertisement

Related Content

Finance Watch: Two New VC Funds Raise $500m; One New US IPO; And Galena's 'Strategic Review'
It Was Shkreli's Show, But Pharma Was On Trial
Shkreli's Ponzi Scheme Trifecta: Lies, Deceit And Greed
Shkreli Arrested On Securities Fraud; KaloBios Hit Hard
Merck CEO: Don't Judge All Pharma On Turing
Biotech Walloped On Clinton Drug Price Controls Threat

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC065350

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel